P

Inventor

FACCHINI PETER J

CA26 patents
⚠️ This page may combine multiple inventors who share the name “FACCHINI PETER J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ENVERIC BIOSCIENCES CANADA INC

25 patents
US11707447B1Jul 25, 2023

C4-carbonothioate-substituted tryptamine derivatives and methods of using

ENVERIC BIOSCIENCES CANADA INC4 citations73
US11891359B2Feb 6, 2024

Prenylated psilocybin derivatives and methods of using

ENVERIC BIOSCIENCES CANADA INC0 citations62
US12138276B2Nov 12, 2024

Halogenated psilocybin derivatives and methods of using

ENVERIC BIOSCIENCES CANADA INC0 citations61
US11998557B2Jun 4, 2024

Halogenated psilocybin derivatives and methods of using

ENVERIC BIOSCIENCES CANADA INC0 citations61
US11945778B2Apr 2, 2024

C4-carbonothioate-substituted tryptamine derivatives and methods of using

ENVERIC BIOSCIENCES CANADA INC0 citations61
US11845726B2Dec 19, 2023

C4-carbonothioate-substituted tryptamine derivatives and methods of using

ENVERIC BIOSCIENCES CANADA INC0 citations61
US12378195B2Aug 5, 2025

Aminated psilocybin derivatives and methods of using

ENVERIC BIOSCIENCES CANADA INC0 citations60
US12187679B2Jan 7, 2025

Hydroxylated psilocybin derivatives and methods of using

ENVERIC BIOSCIENCES CANADA INC0 citations60
US12133856B2Nov 5, 2024

Multi-substituent psilocybin derivatives and methods of using

ENVERIC BIOSCIENCES CANADA INC0 citations60
US12128058B2Oct 29, 2024

Multi-substituent psilocybin derivatives and methods of using

ENVERIC BIOSCIENCES CANADA INC0 citations60
US11931338B2Mar 19, 2024

Nitrilated psilocybin derivatives and methods of using

ENVERIC BIOSCIENCES CANADA INC0 citations60
US11918594B2Mar 5, 2024

Multi-substituent psilocybin derivatives and methods of using

ENVERIC BIOSCIENCES CANADA INC0 citations60
US11891360B2Feb 6, 2024

Glycosylated psilocybin derivatives and methods of using

ENVERIC BIOSCIENCES CANADA INC0 citations60
US11858895B2Jan 2, 2024

Aminated psilocybin derivatives and methods of using

ENVERIC BIOSCIENCES CANADA INC0 citations60
US11845727B2Dec 19, 2023

Aldehyde and ketone derivatives of psilocybin and methods of using

ENVERIC BIOSCIENCES CANADA INC0 citations60
US11752130B2Sep 12, 2023

Carboxylated psilocybin derivatives and methods of using

ENVERIC BIOSCIENCES CANADA INC0 citations60
US12492179B2Dec 9, 2025

Substituted ethylamine fused heterocyclic mescaline derivatives

ENVERIC BIOSCIENCES CANADA INC0 citations59
US12358885B2Jul 15, 2025

Substituted n-propylamine fused heterocyclic mescaline derivatives

ENVERIC BIOSCIENCES CANADA INC0 citations59
US12195439B1Jan 14, 2025

C1-substituted isopropylamine fused heterocyclic mescaline derivatives

ENVERIC BIOSCIENCES CANADA INC0 citations59
US12077498B2Sep 3, 2024

C4-carboxylic acid-substituted tryptamine derivatives and methods of using

ENVERIC BIOSCIENCES CANADA INC0 citations59
US12065404B2Aug 20, 2024

C4-carboxylic acid-substituted tryptamine derivatives and methods of using

ENVERIC BIOSCIENCES CANADA INC0 citations59
US11746087B1Sep 5, 2023

C4-carboxylic acid-substituted tryptamine derivatives and methods of using

ENVERIC BIOSCIENCES CANADA INC0 citations59
US12577232B2Mar 17, 2026

N-heterocycle substituted tryptamine derivatives and methods of using

ENVERIC BIOSCIENCES CANADA INC0 citations58
US12338231B1Jun 24, 2025

N-heterocycle substituted tryptamine derivatives and methods of using

ENVERIC BIOSCIENCES CANADA INC0 citations58
US12428408B2Sep 30, 2025

Fused heterocyclic mescaline derivatives

ENVERIC BIOSCIENCES CANADA INC0 citations48

ANTHEIA INC

1 patent